Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

8 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-03-18

Study Completion Date

2020-10-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

NCT02639767

Malignant Pleural Mesothelioma

WITHDRAWN PHASE1

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma

NCT00054002

Malignant Mesothelioma

COMPLETED PHASE2

Intrapleural Cryotherapy for Malignant Pleural Mesothelioma

NCT02464904

Mesothelioma

TERMINATED NA

Isolated Thoracic Perfusion (ITP-F) for MPM

NCT02467426

Mesothelioma

COMPLETED

Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma

NCT04166734

Advanced Malignant Pleural Mesothelioma

TERMINATED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will consent patients that have been diagnosed with mesothelioma and will undergo chemotherapy followed by surgery and then IMRT as their standard of care. The investigators will collect data from past and future medical records as well as data regarding their health status for their lifetime by reviewing life status, treatment status and CT scans.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mesothelioma Solitary Fibrous Tumor of the Pleura

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject provides informed consent
* Subject is \>18 years of age
* Subject is deemed competent for making medical decisions
* Subject is scheduled to undergo chemotherapy followed by surgery and then IMRT
* Subject is a surgical candidate
* A negative pregnancy test is required in women of child-bearing potential, as standard of care.